Page last updated: 2024-10-28

hydroxychloroquine and Osteoarthritis, Hip

hydroxychloroquine has been researched along with Osteoarthritis, Hip in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Osteoarthritis, Hip: Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion.

Research Excerpts

ExcerptRelevanceReference
"Hydroxychloroquine (HCQ), which has shown its effectiveness in rheumatoid arthritis, has been trialed for the treatment of OA; however, its efficacy and safety remain unclear."2.82Efficacy and safety of hydroxychloroquine in osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. ( Antony, B; Das, S; Dissanayaka, T; Kotlo, A; Singh, A; Wang, Z, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Singh, A1
Kotlo, A1
Wang, Z1
Dissanayaka, T1
Das, S1
Antony, B1

Reviews

1 review available for hydroxychloroquine and Osteoarthritis, Hip

ArticleYear
Efficacy and safety of hydroxychloroquine in osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.
    The Korean journal of internal medicine, 2022, Volume: 37, Issue:1

    Topics: Humans; Hydroxychloroquine; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain; Randomized Controlled T

2022